# Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

> **NCT02400307** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 19 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Bictegravir

## Key facts

- **NCT ID:** NCT02400307
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-17
- **Primary completion:** 2015-07-06
- **Final completion:** 2015-07-13
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400307, "Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02400307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*